{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:06:14Z","timestamp":1792728374808,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":1344,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005737","name":"Universit\u00e9 Pierre et Marie Curie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007393","name":"Association Fran\u00e7aise contre les Myopathies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007393","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1038\/mt.2012.261","type":"journal-article","created":{"date-parts":[[2013,1,8]],"date-time":"2013-01-08T09:55:04Z","timestamp":1357638904000},"page":"282-290","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":122,"title":["Intramuscular scAAV9-SMN Injection Mediates Widespread Gene Delivery to the Spinal Cord and Decreases Disease Severity in SMA Mice"],"prefix":"10.1016","volume":"21","author":[{"given":"Sofia","family":"Benkhelifa-Ziyyat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurore","family":"Besse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Roda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Duque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Astord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Carcenac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaut","family":"Marais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Barkats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2012.261_bib1","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1172\/JCI22922","article-title":"Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy","volume":"114","author":"Azzouz","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2012.261_bib2","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nature02544","article-title":"VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model","volume":"429","author":"Azzouz","year":"2004","journal-title":"Nature"},{"key":"10.1038\/mt.2012.261_bib3","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1006\/exnr.1998.6878","article-title":"Neuroprotection of spinal motoneurons following targeted transduction with an adenoviral vector carrying the gene for glial cell line-derived neurotrophic factor","volume":"153","author":"Baumgartner","year":"1998","journal-title":"Exp Neurol"},{"key":"10.1038\/mt.2012.261_bib4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/(SICI)1097-4547(19970501)48:3<281::AID-JNR11>3.0.CO;2-4","article-title":"Prevention of motoneuron death by adenovirus-mediated neurotrophic factors","volume":"48","author":"Gimenez y Ribotta","year":"1997","journal-title":"J Neurosci Res"},{"key":"10.1038\/mt.2012.261_bib5","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1126\/science.1086137","article-title":"Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model","volume":"301","author":"Kaspar","year":"2003","journal-title":"Science"},{"key":"10.1038\/mt.2012.261_bib6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0168-0102(02)00195-5","article-title":"Intramuscular injection of AAV-GDNF results in sustained expression of transgenic GDNF, and its delivery to spinal motoneurons by retrograde transport","volume":"45","author":"Lu","year":"2003","journal-title":"Neurosci Res"},{"key":"10.1038\/mt.2012.261_bib7","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/00001756-199512000-00088","article-title":"Specific and efficient gene transfer strategy offers new potentialities for the treatment of motor neurone diseases","volume":"7","author":"Finiels","year":"1995","journal-title":"Neuroreport"},{"key":"10.1038\/mt.2012.261_bib8","doi-asserted-by":"crossref","first-page":"7781","DOI":"10.1128\/JVI.00481-06","article-title":"A common mechanism for cytoplasmic dynein-dependent microtubule binding shared among adeno-associated virus and adenovirus serotypes","volume":"80","author":"Kelkar","year":"2006","journal-title":"J Virol"},{"key":"10.1038\/mt.2012.261_bib9","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1093\/hmg\/10.19.2109","article-title":"Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery","volume":"10","author":"Mazarakis","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2012.261_bib10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/gt.2009.119","article-title":"Efficient transduction of non-human primate motor neurons after intramuscular delivery of recombinant AAV serotype 6","volume":"17","author":"Towne","year":"2010","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2012.261_bib11","article-title":"Widespread gene delivery to motor neurons using peripheral injection of AAV vectors","author":"Barkats","year":"2007","journal-title":"PCT\/EP2008\/063297 GENETHON\/CNRS"},{"key":"10.1038\/mt.2012.261_bib12","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/mt.2009.71","article-title":"Intravenous administration of self-complementary AAV9 enables transgene delivery to adult motor neurons","volume":"17","author":"Duque","year":"2009","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2012.261_bib13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nbt.1515","article-title":"Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes","volume":"27","author":"Foust","year":"2009","journal-title":"Nat Biotechnol"},{"key":"10.1038\/mt.2012.261_bib14","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/mt.2011.157","article-title":"Systemic gene delivery in large species for targeting spinal cord, brain, and peripheral tissues for pediatric disorders","volume":"19","author":"Bevan","year":"2011","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2012.261_bib15","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/mt.2011.72","article-title":"Preclinical differences of intravascular AAV9 delivery to neurons and glia: a comparative study of adult mice and nonhuman primates","volume":"19","author":"Gray","year":"2011","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2012.261_bib16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"key":"10.1038\/mt.2012.261_bib17","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/hmg\/ddi078","article-title":"SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN","volume":"14","author":"Le","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2012.261_bib18","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/hmg\/ddq514","article-title":"Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice","volume":"20","author":"Dominguez","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2012.261_bib19","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nbt.1610","article-title":"Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN","volume":"28","author":"Foust","year":"2010","journal-title":"Nat Biotechnol"},{"key":"10.1038\/mt.2012.261_bib20","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.molmed.2011.01.002","article-title":"Prospects for the gene therapy of spinal muscular atrophy","volume":"17","author":"Passini","year":"2011","journal-title":"Trends Mol Med"},{"key":"10.1038\/mt.2012.261_bib21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/156652310791111047","article-title":"Effect of administration route on the biodistribution and shedding of replication-deficient AAV2: a qualitative modelling approach","volume":"10","author":"Brandon","year":"2010","journal-title":"Curr Gene Ther"},{"key":"10.1038\/mt.2012.261_bib22","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nbt1073","article-title":"Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart","volume":"23","author":"Wang","year":"2005","journal-title":"Nat Biotechnol"},{"key":"10.1038\/mt.2012.261_bib23","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1089\/hum.2009.131","article-title":"Efficient retrograde transport of adeno-associated virus type 8 to spinal cord and dorsal root ganglion after vector delivery in muscle","volume":"21","author":"Zheng","year":"2010","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2012.261_bib24","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/sj.mt.6300367","article-title":"Efficient retrograde neuronal transduction utilizing self-complementary AAV1","volume":"16","author":"Hollis","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2012.261_bib25","doi-asserted-by":"crossref","first-page":"35ra42","DOI":"10.1126\/scitranslmed.3000830","article-title":"Systemic delivery of scAAV9 expressing SMN prolongs survival in a model of spinal muscular atrophy","volume":"2","author":"Valori","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1038\/mt.2012.261_bib26","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/71709","article-title":"A mouse model for spinal muscular atrophy","volume":"24","author":"Hsieh-Li","year":"2000","journal-title":"Nat Genet"},{"key":"10.1038\/mt.2012.261_bib27","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/ana.21449","article-title":"Sustained improvement of spinal muscular atrophy mice treated with trichostatin A plus nutrition","volume":"64","author":"Narver","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1038\/mt.2012.261_bib28","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.nbd.2011.06.021","article-title":"IGF-1 delivery to CNS attenuates motor neuron cell death but does not improve motor function in type III SMA mice","volume":"45","author":"Tsai","year":"2012","journal-title":"Neurobiol Dis"},{"key":"10.1038\/mt.2012.261_bib29","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/mt.2011.303","article-title":"Microvesicle-associated AAV vector as a novel gene delivery system","volume":"20","author":"Maguire","year":"2012","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2012.261_bib30","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s13311-011-0074-9","article-title":"Neurotrophins: potential therapeutic tools for the treatment of spinal cord injury","volume":"8","author":"Hollis","year":"2011","journal-title":"Neurotherapeutics"},{"key":"10.1038\/mt.2012.261_bib31","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00429-002-0233-1","article-title":"Targeting functional subtypes of spinal motoneurons and skeletal muscle fibers in vivo by intramuscular injection of adenoviral and adeno-associated viral vectors","volume":"205","author":"Martinov","year":"2002","journal-title":"Anat Embryol"},{"key":"10.1038\/mt.2012.261_bib32","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/sj.gt.3300946","article-title":"Titration of AAV-2 particles via a novel capsid ELISA: packaging of genomes can limit production of recombinant AAV-2","volume":"6","author":"Grimm","year":"1999","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2012.261_bib33","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1089\/hgtb.2012.090","article-title":"Limitations of encapsidation of recombinant scAAV2 genomes in different serotype capsids and their quantitation","volume":"23","author":"Wang","year":"2012","journal-title":"Hum Gene Ther Methods"},{"key":"10.1038\/mt.2012.261_bib34","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1089\/hum.1997.8.16-1911","article-title":"Transfer of contaminants in adeno-associated virus vector stocks can mimic transduction and lead to artifactual results","volume":"8","author":"Alexander","year":"1997","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2012.261_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/hgtb.2011.104","article-title":"Systemic errors in quantitative polymerase chain reaction titration of self-complementary adeno-associated viral vectors and improved alternative methods","volume":"23","author":"Fagone","year":"2012","journal-title":"Hum Gene Ther Methods"},{"key":"10.1038\/mt.2012.261_bib36","doi-asserted-by":"crossref","first-page":"6620","DOI":"10.1128\/JVI.00297-12","article-title":"Human galectin 3 binding protein interacts with recombinant adeno-associated virus type 6","volume":"86","author":"Denard","year":"2012","journal-title":"J Virol"},{"key":"10.1038\/mt.2012.261_bib37","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nature10485","article-title":"Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model","volume":"478","author":"Hua","year":"2011","journal-title":"Nature"},{"key":"10.1038\/mt.2012.261_bib38","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/ana.23582","article-title":"Glucose metabolism and pancreatic defects in spinal muscular atrophy","volume":"72","author":"Bowerman","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1038\/mt.2012.261_bib39","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1093\/hmg\/ddr360","article-title":"Reversible molecular pathology of skeletal muscle in spinal muscular atrophy","volume":"20","author":"Mutsaers","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2012.261_bib40","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1093\/hmg\/ddq329","article-title":"Cardiac defects contribute to the pathology of spinal muscular atrophy models","volume":"19","author":"Shababi","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2012.261_bib41","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.1093\/hmg\/ddq300","article-title":"Early heart failure in the SMNDelta7 model of spinal muscular atrophy and correction by postnatal scAAV9-SMN delivery","volume":"19","author":"Bevan","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2012.261_bib42","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.mcn.2011.12.003","article-title":"SMN deficiency attenuates migration of U87MG astroglioma cells through the activation of RhoA","volume":"49","author":"Caraballo-Miralles","year":"2012","journal-title":"Mol Cell Neurosci"},{"key":"10.1038\/mt.2012.261_bib43","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.2174\/1389450111007011250","article-title":"Skeletal muscle in motor neuron diseases: therapeutic target and delivery route for potential treatments","volume":"11","author":"Dupuis","year":"2010","journal-title":"Curr Drug Targets"},{"key":"10.1038\/mt.2012.261_bib44","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1093\/hmg\/ddq330","article-title":"Arrhythmia and cardiac defects are a feature of spinal muscular atrophy model mice","volume":"19","author":"Heier","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2012.261_bib45","doi-asserted-by":"crossref","first-page":"e15457","DOI":"10.1371\/journal.pone.0015457","article-title":"Synaptic defects in the spinal and neuromuscular circuitry in a mouse model of spinal muscular atrophy","volume":"5","author":"Ling","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1038\/mt.2012.261_bib46","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.neuron.2010.12.032","article-title":"Early functional impairment of sensory-motor connectivity in a mouse model of spinal muscular atrophy","volume":"69","author":"Mentis","year":"2011","journal-title":"Neuron"},{"key":"10.1038\/mt.2012.261_bib47","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1089\/10430349950017563","article-title":"Purification of recombinant adeno-associated virus by iodixanol gradient ultracentrifugation allows rapid and reproducible preparation of vector stocks for gene transfer in the nervous system","volume":"10","author":"Hermens","year":"1999","journal-title":"Hum Gene Ther"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616305883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616305883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T16:13:16Z","timestamp":1777997596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616305883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S1525001616305883"],"URL":"https:\/\/doi.org\/10.1038\/mt.2012.261","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717976143.793502454","asserted-by":"object"}]},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intramuscular scAAV9-SMN Injection Mediates Widespread Gene Delivery to the Spinal Cord and Decreases Disease Severity in SMA Mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/mt.2012.261","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The American Society of Gene & Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}